| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 09:38 | Physitrack PLC: Physitrack Announces CHF 150,000 Deal with Swiss Care Provider | 175 | ACCESS Newswire | LONDON, GB / ACCESS Newswire / March 27, 2026 / Physitrack PLC (STO:PTRK) - Physitrack Plc announces agreement with leading Swiss rehabilitation group worth 150,000 over four years with CHF 75,000 in... ► Artikel lesen | |
| 12.03. | Physitrack PLC Publishes 2025 Audited Annual Report | 244 | ACCESS Newswire | LONDON, UK / ACCESS Newswire / March 12, 2026 / Physitrack PLC (STO:PTRK)("Physitrack" or the "Company"), listed on Nasdaq First North Premier Growth Market (PTRK), today announces the publication of... ► Artikel lesen | |
| 10.03. | Physitrack PLC: Physitrack Announces Agreement with Lleading Swiss Healthcare Organisation | 351 | ACCESS Newswire | LONDON, UK / ACCESS Newswire / March 10, 2026 / Physitrack PLC (STO:PTRK) has reached an agreement with a major Swiss Health Care organisation. The deal is worth 149,985 CHF (approximately 156,000 EUR)... ► Artikel lesen | |
| 06.03. | Physitrack Plc Announces Update on Publication of Annual Report | 295 | ACCESS Newswire | LONDON, UK / ACCESS Newswire / March 6, 2026 / Physitrack PLC (STO:PTRK)(Nasdaq First North:PTRK) ("Physitrack" or the "Company") announces an update regarding the timing of the publication of its Annual... ► Artikel lesen | |
| 27.02. | Physitrack steigert Cashflow und Profitabilität im Q4 2025 | 3 | Investing.com Deutsch | ||
| 27.02. | Physitrack PLC: Physitrack Plc: Year-end report Q4 and full year 2025 - Improved profitability and sustained positive cash flow | 111 | GlobeNewswire (Europe) | Physitrack Plc ("Physitrack" or the "Company"), listed on Nasdaq First North Growth Market (ticker: PTRK), today publishes its Year-end report for the fourth quarter and full year 2025.
Company announcement... ► Artikel lesen | |
| PHYSITRACK Aktie jetzt für 0€ handeln | |||||
| 26.02. | Physitrack Plc Announces Update on Publication of Annual Report | 221 | ACCESS Newswire | Physitrack PLC (Nasdaq First North:PTRK) ("Physitrack" or the "Company") announces that its audited Q4 2025 report will be published on 27 February 2026 as planned, while the Annual Report will be published... ► Artikel lesen | |
| 20.02. | Physitrack PLC Announces Intention to Implement Share Buyback Program | 306 | ACCESS Newswire | Physitrack's Board of Directors has approved the intention to implement a share buyback program (the "SBB"), subject to lender consent and prevailing market conditions. LONDON, GB / ACCESS Newswire... ► Artikel lesen | |
| 20.02. | Invitation to Physitrack PLC Q4 2025 Interim Report Webcast Conference | 240 | ACCESS Newswire | LONDON, GB / ACCESS Newswire / February 20, 2026 / Physitrack PLC (STO:PTRK) - The global digital healthcare provider Physitrack PLC (PTRK) plans to publish its Q4 2025 interim report on February 27... ► Artikel lesen | |
| 16.02. | Physitrack PLC Announces Change of Annual General Meeting Date | 332 | ACCESS Newswire | LONDON, GB / ACCESS Newswire / February 16, 2026 / Physitrack PLC (Nasdaq First North:PTRK)(STO:PTRK) announces that the date of its Annual General Meeting ("AGM") has been changed to May 26.Physitrack's... ► Artikel lesen | |
| 29.01. | Physitrack PLC - Unaudited FY2025 Trading Update and Preliminary Results | 287 | ACCESS Newswire | Delivering a EUR 1.9m year-on-year improvement in free cash flow, reflecting a stronger, more focused and cash-generative SaaS business. LONDON, GB / ACCESS Newswire / January 29, 2026 / Physitrack... ► Artikel lesen | |
| 06.01. | Physitrack PLC Appoints Matthew Poulter as Chief Financial Officer | 392 | ACCESS Newswire | LONDON, UK / ACCESS Newswire / January 6, 2026 / Physitrack PLC (Nasdaq First North:PTRK)(STO:PTRK) announces that Matthew Poulter has been appointed Chief Financial Officer (CFO) on a permanent basis.Physitrack... ► Artikel lesen | |
| 05.01. | Physitrack PLC Clarifies Reporting Calendar and Announces January 29 Preliminary Results Trading Update | 286 | ACCESS Newswire | LONDON, UK / ACCESS Newswire / January 5, 2026 / Physitrack PLC (STO:PTRK) clarifies that the Company's Q4 and Annual Report for the year ended 31 December 2025 will be published on Friday, 27 February... ► Artikel lesen | |
| 11.12.25 | Physitrack PLC Announces Appointment of US-based Head of Marketing | 440 | ACCESS Newswire | LONDON, GB / ACCESS Newswire / December 11, 2025 / Physitrack PLC (Nasdaq First North:PTRK)(STO:PTRK) is pleased to announce the appointment of Kevin Kaminyar as its new Head of Marketing.Kevin will... ► Artikel lesen | |
| 24.11.25 | Physitrack PLC: Physitrack announces strategic restructure of Wellness division to focus on high-margin SaaS growth in 2026 | 288 | GlobeNewswire (Europe) | London, 24 November 2025 - Physitrack PLC ("Physitrack") announces the continued restructuring of its Wellness division as part of the Group's strategy to focus on high-margin, recurring-revenue software... ► Artikel lesen | |
| 21.10.25 | Physitrack Q3 2025: Umsatz steigt, Aktie fällt deutlich | 2 | Investing.com Deutsch | ||
| 21.10.25 | Physitrack PLC - Interim Report: January - September 2025 | 406 | ACCESS Newswire | LONDON, GB / ACCESS Newswire / October 21, 2025 / Physitrack PLC (STO:PTRK) - Fourth Consecutive Quarter of Resilient, Cash-Generative Growth, Marking Historical Positive Cash flow.Investor snapshotMetricQ3... ► Artikel lesen | |
| 21.10.25 | Physitrack PLC Q3 Sales Decline | 2 | RTTNews | ||
| 14.10.25 | Invitation to Physitrack PLC Q3 2025 Interim Report Webcast Conference | 232 | ACCESS Newswire | LONDON, GB / ACCESS Newswire / October 14, 2025 / Physitrack PLC (STO:PTRK) - The global digital healthcare provider Physitrack PLC (PTRK) plans to publish its Q3 2025 interim report on October 21,... ► Artikel lesen | |
| 25.09.25 | Physitrack Plc Announces Deal with European Insurer to Launch Consumer-facing Self-management Product | 341 | ACCESS Newswire | Physitrack PLC (STO:PTRK) - First phase of agreement generates €55,000 of upfront and €24,000 annual recurring revenue, strengthens Physitrack's presence in direct to consumer offering. LONDON, UK /... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SIEMENS HEALTHINEERS | 35,990 | -0,91 % | EQS-DD: Siemens Healthineers AG: Dorothea Simon, Kauf | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
20.03.2026 / 16:23... ► Artikel lesen | |
| FRESENIUS | 43,970 | -0,20 % | EQS-DD: Fresenius SE & Co. KGaA: Sara Hennicken, Kauf | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
20.03.2026 / 09:22... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 38,860 | -0,21 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| FIREFLY NEUROSCIENCE | 3,000 | 0,00 % | Firefly Neuroscience, Inc.: Firefly Confirms Public-Private Partnership with the Department of War | Firefly's AI-powered, FDA-cleared EEG/ERP Technology is Being Deployed to Support Assessment and Treatment of PTSD and TBI in U.S. Service Members Partnership Represents a Significant Expansion of... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 42,820 | 0,00 % | Brightspring-Aktie erreicht Rekordhoch von 44,88 USD | ||
| ECKERT & ZIEGLER | 14,370 | -4,64 % | EQS-DD: Eckert & Ziegler SE: Dr. Harald Hasselmann, Zuteilung von 62.541 Aktien als Vergütungsbestandteil im Rahmen der Vorstandsvergütung (eigene Aktien des Emittenten). Es handelt sich um ... | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
24.03.2026 / 10:04... ► Artikel lesen | |
| GENEDX | 61,26 | 0,00 % | Craig-Hallum Reaffirms Buy on GeneDx (WGS) With $153 Price Target | ||
| PROCEPT BIOROBOTICS | 25,070 | 0,00 % | PROCEPT BioRobotics: EAU Guidelines Upgrade Aquablation Therapy to Strong Surgical Recommendation for BPH | Updated European Association of Urology guidelines reflect growing clinical evidence supporting Aquablation therapy in the surgical treatment of benign prostatic hyperplasiaSAN JOSE, Calif., March 23... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 24,300 | -2,80 % | XETR MODIFICATIONS OF SHARE INDICES EFFECTIVE 23 MARCH 2026 | For the following instruments, the Product Assignment Group in Xetra (MIC: XETR) will change with effect from 23 March 2026Instrument Mnemonic ISIN Product Assignment Group (old) Product Assignment... ► Artikel lesen | |
| HEARTFLOW | 25,870 | 0,00 % | Heartflow, Inc.: Heartflow FFRCT Analysis Delivers Prognostic Power and Significant Cost Savings in New Analyses of Over 90,000 Patients with Coronary Artery Disease | Lesion-specific FFRCT predicts individual cardiovascular outcomes and delivers greater-than-modeled cost savings for real-world population in FISH&CHIPS analyses from England's National Health ServiceMOUNTAIN... ► Artikel lesen | |
| LUMEXA IMAGING | 7,785 | 0,00 % | Lumexa Imaging, Inc.: Lumexa Imaging Announces Fourth Quarter and Full Year 2025 Results, Reiterates Full Year 2026 Guidance | RALEIGH, N.C., March 26, 2026 (GLOBE NEWSWIRE) -- Lumexa Imaging (Nasdaq: LMRI), one of the nation's largest providers of outpatient imaging services, today announced certain financial results for... ► Artikel lesen | |
| DRAEGERWERK | 91,60 | -1,82 % | Ihre wichtigsten Termine: Frische Zahlen von: Kingfisher, Drägerwerk & Bellway sowie neue Konjunkturdaten | © Foto: Axel Heimken - dpaGut geplant in den Tag. Mit dem wO-Tagesausblick haben Sie die wichtigsten Termine im Blick und starten bestens vorbereitet in den neuen Handelstag.Unternehmenstermine 07:30... ► Artikel lesen | |
| BILLIONTOONE | 71,24 | -7,48 % | BillionToOne, Inc.: BillionToOne Reports Fourth Quarter and Full Year 2025 Results and Raises 2026 Revenue Guidance | MENLO PARK, Calif., March 04, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that... ► Artikel lesen | |
| PROGYNY | 17,770 | 0,00 % | Progyny, Inc. Announces Third Quarter 2025 Results | Reports Revenue of $313.3 Million, Reflecting 9.3% GrowthRaises Full Year Guidance to Reflect Continued Strength in Member EngagementSelling Season Yields Over 80 New Clients, 900,000 New Lives, and... ► Artikel lesen | |
| PROFOUND MEDICAL | 6,280 | 0,00 % | Profound Medical Corp.: Profound Medical Congratulates Texas Prostate on Achieving 100th TULSA Procedure Milestone |